Foley Mark J Insider Trades

Insider Trading History

Track insider trading activity for Foley Mark J. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Glaukos
Glaukos GKOS
Director
Holding Value $6.85M 60,267 shares
Last Trade
May 28, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$518k 4,865 shares
$106.52
$113.64
Glaukos
Glaukos GKOS
Director
Holding Value $6.64M 58,389 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$129k 1,168 shares
$110.72
$113.64
Glaukos
Glaukos GKOS
Director
Holding Value $6.5M 57,221 shares
Last Trade
May 29, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$299k 3,149 shares
$94.87
$113.64
Glaukos
Glaukos GKOS
Director
Holding Value $0 0 shares
Last Trade
Feb 26, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$4.82M 40,000 shares
$120.49
$113.64
Glaukos
Glaukos GKOS
Director
Holding Value $8.52M 74,936 shares
Last Trade
Feb 26, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$4.82M 40,000 shares
$120.49
$113.64
Glaukos
Glaukos GKOS
Director
Holding Value $6.16M 54,249 shares
Last Trade
Feb 26, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.5M 20,687 shares
$120.72
$113.64
Revance Therapeutics
Revance Therapeutics RVNC
President & CEO
Holding Value $0 0 shares
Last Trade
Feb 06, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$309k 84,686 shares
$3.65
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
President & CEO
Holding Value $309k 84,686 shares
Last Trade
Feb 06, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$309k 84,686 shares
$3.65
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
President & CEO
Holding Value $102k 27,933 shares
Last Trade
Feb 04, 2025 Sale (Tender)Reported as Tender on SEC Form 4.
$4.04M 1,107,848 shares
$3.65
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
CEO
Holding Value $3.74M 1,024,868 shares
Last Trade
Feb 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$102k 27,933 shares
$3.64
$3.65
Glaukos
Glaukos GKOS
Director
Holding Value $4.07M 35,800 shares
Last Trade
Jan 02, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$129k 864 shares
$149.68
$113.64
Revance Therapeutics
Revance Therapeutics RVNC
CEO
Holding Value $3.64M 996,935 shares
Last Trade
Dec 31, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.04k 1,000 shares
$3.04
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
CEO
Holding Value $3.64M 995,935 shares
Last Trade
Jun 30, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.57k 1,000 shares
$2.57
$3.65
Glaukos
Glaukos GKOS
Director
Holding Value $3.97M 34,936 shares
Last Trade
May 30, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$138k 1,246 shares
$110.70
$113.64
Revance Therapeutics
Revance Therapeutics RVNC
CEO
Holding Value $3.69M 1,012,163 shares
Last Trade
Mar 15, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$109k 20,533 shares
$5.31
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
CEO
Holding Value $3.71M 1,015,468 shares
Last Trade
Mar 06, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$190k 30,000 shares
$6.34
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
CEO
Holding Value $3.6M 985,468 shares
Last Trade
Feb 29, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$505k 70,750 shares
$7.14
$3.65
Glaukos
Glaukos GKOS
Director
Holding Value $0 0 shares
Last Trade
Feb 23, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$896k 10,000 shares
$89.57
$113.64
Glaukos
Glaukos GKOS
Director
Holding Value $3.78M 33,220 shares
Last Trade
Feb 23, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$423k 4,560 shares
$92.87
$113.64
Glaukos
Glaukos GKOS
Director
Holding Value $4.29M 37,780 shares
Last Trade
Feb 23, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$896k 10,000 shares
$89.57
$113.64

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up